NCT03350373View on ClinicalTrials.gov

Clinical Pharmacology of FYU-981 (Final Formulation)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

November 29, 2017

Study Completion Date

November 29, 2017

Conditions
Healthy
Interventions
DRUG

FYU-981

Single administration of FYU-981 under Fasted and fed conditions in the morning.

Trial Locations (1)

192-0071

P-One Clinic, Hachiōji

Sponsors

Collaborators (1)

Fuji Yakuhin Co., Ltd.
All Listed Sponsors
collaborator

Fuji Yakuhin Co., Ltd.

INDUSTRY

lead

Mochida Pharmaceutical Company, Ltd.

INDUSTRY

NCT03350373 - Clinical Pharmacology of FYU-981 (Final Formulation) | Biotech Hunter | Biotech Hunter